

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.44503966 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.43036321 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.14468264 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.90638125 |
| 5 | glutamate secretion (GO:0014047) | 4.84901068 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.80254254 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.79214097 |
| 8 | locomotory exploration behavior (GO:0035641) | 4.39280063 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 4.23952761 |
| 10 | vocalization behavior (GO:0071625) | 4.18233481 |
| 11 | neurotransmitter secretion (GO:0007269) | 4.08721576 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.05506432 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.04910987 |
| 14 | proline transport (GO:0015824) | 4.00431758 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.98414176 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.97643955 |
| 17 | response to peptidoglycan (GO:0032494) | 3.92331101 |
| 18 | neuronal action potential propagation (GO:0019227) | 3.91120663 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 3.89820265 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.88543805 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77895041 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77895041 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.77895041 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77895041 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.77895041 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77895041 |
| 27 | protein localization to synapse (GO:0035418) | 3.77180299 |
| 28 | exploration behavior (GO:0035640) | 3.68711813 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 3.68572630 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.67232672 |
| 31 | * transferrin transport (GO:0033572) | 3.65685002 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62904160 |
| 33 | glycosphingolipid catabolic process (GO:0046479) | 3.60518656 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.57223094 |
| 35 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.56436669 |
| 36 | * ATP hydrolysis coupled proton transport (GO:0015991) | 3.56436669 |
| 37 | detection of other organism (GO:0098543) | 3.55506025 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54669598 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.54669598 |
| 40 | granulocyte activation (GO:0036230) | 3.53300604 |
| 41 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.49008700 |
| 42 | regulation of synapse structural plasticity (GO:0051823) | 3.47495611 |
| 43 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.46043794 |
| 44 | amino sugar catabolic process (GO:0046348) | 3.44830215 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.43270931 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.40085829 |
| 47 | * trivalent inorganic cation transport (GO:0072512) | 3.39720384 |
| 48 | * ferric iron transport (GO:0015682) | 3.39720384 |
| 49 | detection of bacterium (GO:0016045) | 3.39051819 |
| 50 | neuromuscular process controlling posture (GO:0050884) | 3.36210254 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.35468892 |
| 52 | neutrophil activation (GO:0042119) | 3.35274894 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.34910599 |
| 54 | glycolipid catabolic process (GO:0019377) | 3.29365874 |
| 55 | neurotransmitter transport (GO:0006836) | 3.26230349 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.25334460 |
| 57 | glutamate receptor signaling pathway (GO:0007215) | 3.24825055 |
| 58 | respiratory burst (GO:0045730) | 3.17254565 |
| 59 | cerebellar Purkinje cell layer development (GO:0021680) | 3.15850132 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15246224 |
| 61 | * phagosome maturation (GO:0090382) | 3.14833773 |
| 62 | neuron recognition (GO:0008038) | 3.14146112 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.13004179 |
| 64 | neuron-neuron synaptic transmission (GO:0007270) | 3.11908425 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.11568452 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 3.10843132 |
| 67 | activation of protein kinase A activity (GO:0034199) | 3.09527585 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 3.07693836 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07639105 |
| 70 | sodium ion export (GO:0071436) | 3.05346806 |
| 71 | detection of external biotic stimulus (GO:0098581) | 3.05233784 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04965010 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04436850 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03634345 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03403870 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 3.03212279 |
| 77 | oligosaccharide catabolic process (GO:0009313) | 3.01724799 |
| 78 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00952801 |
| 79 | macrophage activation (GO:0042116) | 3.00952272 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99989322 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.99001294 |
| 82 | positive regulation of mast cell activation (GO:0033005) | 2.97101885 |
| 83 | positive regulation of mast cell degranulation (GO:0043306) | 2.96924410 |
| 84 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96924410 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 2.96499862 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 2.96294727 |
| 87 | negative regulation of amino acid transport (GO:0051956) | 2.95769144 |
| 88 | myeloid cell activation involved in immune response (GO:0002275) | 2.95477171 |
| 89 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.95267381 |
| 90 | long-term synaptic potentiation (GO:0060291) | 2.95007253 |
| 91 | dendritic spine morphogenesis (GO:0060997) | 2.94798340 |
| 92 | regulation of regulated secretory pathway (GO:1903305) | 2.94531882 |
| 93 | synaptic vesicle transport (GO:0048489) | 2.93930342 |
| 94 | establishment of synaptic vesicle localization (GO:0097480) | 2.93930342 |
| 95 | ceramide catabolic process (GO:0046514) | 2.93538694 |
| 96 | vesicle transport along microtubule (GO:0047496) | 2.91828281 |
| 97 | positive regulation of synapse maturation (GO:0090129) | 2.91774290 |
| 98 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91001322 |
| 99 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90791341 |
| 100 | alanine transport (GO:0032328) | 2.90076517 |
| 101 | axonal fasciculation (GO:0007413) | 2.89590582 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.89300187 |
| 103 | negative regulation of microtubule polymerization (GO:0031115) | 2.89015960 |
| 104 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.88904882 |
| 105 | mating behavior (GO:0007617) | 2.87932386 |
| 106 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87871190 |
| 107 | barbed-end actin filament capping (GO:0051016) | 2.87822165 |
| 108 | neuromuscular process controlling balance (GO:0050885) | 2.85937990 |
| 109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.85592865 |
| 110 | positive regulation of leukocyte degranulation (GO:0043302) | 2.84053314 |
| 111 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.83406870 |
| 112 | regulation of early endosome to late endosome transport (GO:2000641) | 2.83037970 |
| 113 | positive regulation of vesicle fusion (GO:0031340) | 2.82645659 |
| 114 | positive regulation of exocytosis (GO:0045921) | 2.79823221 |
| 115 | positive regulation of membrane potential (GO:0045838) | 2.79814454 |
| 116 | regulation of postsynaptic membrane potential (GO:0060078) | 2.79060100 |
| 117 | cellular extravasation (GO:0045123) | 2.77252273 |
| 118 | long-term memory (GO:0007616) | 2.76601176 |
| 119 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.76438130 |
| 120 | response to histamine (GO:0034776) | 2.75492221 |
| 121 | regulation of neurotransmitter transport (GO:0051588) | 2.74856104 |
| 122 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.74696088 |
| 123 | clathrin coat assembly (GO:0048268) | 2.72711450 |
| 124 | establishment of vesicle localization (GO:0051650) | 2.72294596 |
| 125 | NIK/NF-kappaB signaling (GO:0038061) | 2.72078166 |
| 126 | N-acetylneuraminate metabolic process (GO:0006054) | 2.71684271 |
| 127 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70973230 |
| 128 | leukocyte aggregation (GO:0070486) | 2.70853829 |
| 129 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.69948138 |
| 130 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.69838478 |
| 131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.69375939 |
| 132 | protein localization to endosome (GO:0036010) | 2.69101700 |
| 133 | regulation of exocytosis (GO:0017157) | 2.68703479 |
| 134 | positive regulation of regulated secretory pathway (GO:1903307) | 2.67716467 |
| 135 | regulation of glutamate secretion (GO:0014048) | 2.67632206 |
| 136 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.67339476 |
| 137 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66595287 |
| 138 | organelle transport along microtubule (GO:0072384) | 2.65757254 |
| 139 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.64052671 |
| 140 | amyloid precursor protein catabolic process (GO:0042987) | 2.64017869 |
| 141 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.62985540 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.62938428 |
| 143 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.62543170 |
| 144 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.61566552 |
| 145 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60781475 |
| 146 | microglial cell activation (GO:0001774) | 2.60362301 |
| 147 | cell migration in hindbrain (GO:0021535) | 2.60080471 |
| 148 | sphingolipid catabolic process (GO:0030149) | 2.60008483 |
| 149 | signal release (GO:0023061) | 2.59156831 |
| 150 | axon cargo transport (GO:0008088) | 2.57988348 |
| 151 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.57980478 |
| 152 | glycine transport (GO:0015816) | 2.57913805 |
| 153 | membrane lipid catabolic process (GO:0046466) | 2.57678232 |
| 154 | innervation (GO:0060384) | 2.56990383 |
| 155 | eosinophil chemotaxis (GO:0048245) | 2.56257693 |
| 156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56015800 |
| 157 | dendrite morphogenesis (GO:0048813) | 2.55988838 |
| 158 | regulation of ARF protein signal transduction (GO:0032012) | 2.55964411 |
| 159 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.55249952 |
| 160 | positive regulation of synaptic transmission (GO:0050806) | 2.55131395 |
| 161 | detection of biotic stimulus (GO:0009595) | 2.55055338 |
| 162 | regulation of mononuclear cell migration (GO:0071675) | 2.55010644 |
| 163 | regulation of superoxide anion generation (GO:0032928) | 2.54017128 |
| 164 | positive regulation of neurotransmitter transport (GO:0051590) | 2.53493392 |
| 165 | prepulse inhibition (GO:0060134) | 2.53423109 |
| 166 | regulation of synaptic transmission (GO:0050804) | 2.53223639 |
| 167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.52887808 |
| 168 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.51810079 |
| 169 | synaptic transmission (GO:0007268) | 2.51524562 |
| 170 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.51106064 |
| 171 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.49124701 |
| 172 | regulation of monocyte chemotaxis (GO:0090025) | 2.47398830 |
| 173 | response to host immune response (GO:0052572) | 2.45946531 |
| 174 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.45946531 |
| 175 | type I interferon signaling pathway (GO:0060337) | 2.42675911 |
| 176 | cellular response to type I interferon (GO:0071357) | 2.42675911 |
| 177 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37814836 |
| 178 | response to type I interferon (GO:0034340) | 2.36059121 |
| 179 | neutrophil chemotaxis (GO:0030593) | 2.34583698 |
| 180 | cellular response to arsenic-containing substance (GO:0071243) | 2.33191924 |
| 181 | myeloid leukocyte activation (GO:0002274) | 2.32685060 |
| 182 | germinal center formation (GO:0002467) | 2.32242978 |
| 183 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.32213148 |
| 184 | regulation of antigen processing and presentation (GO:0002577) | 2.31591624 |
| 185 | B cell mediated immunity (GO:0019724) | 2.30829394 |
| 186 | neutrophil mediated immunity (GO:0002446) | 2.30591076 |
| 187 | reactive oxygen species biosynthetic process (GO:1903409) | 2.30098335 |
| 188 | eosinophil migration (GO:0072677) | 2.29503773 |
| 189 | negative regulation of interleukin-6 production (GO:0032715) | 2.28716125 |
| 190 | myeloid dendritic cell differentiation (GO:0043011) | 2.28200626 |
| 191 | neutrophil migration (GO:1990266) | 2.27988364 |
| 192 | response to thyroid hormone (GO:0097066) | 2.27751317 |
| 193 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.27332933 |
| 194 | regulation of macrophage chemotaxis (GO:0010758) | 2.27202791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.17761905 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.35690986 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.97400575 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78502425 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.15722391 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96117196 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78226803 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77931861 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.73399514 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72969698 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.64182866 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.64028204 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61931183 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.59815530 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53906415 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.52459089 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51190444 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49901517 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49412699 |
| 20 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44907472 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43520780 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43520780 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.42676770 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39926497 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38231313 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38140034 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32594904 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.31665417 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14587758 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 2.14573414 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.12350671 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04884906 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03910180 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03878994 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01173977 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01070364 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01067301 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93110253 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93014678 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92939825 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91475706 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88313277 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87613750 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.87024619 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85283383 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79251043 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78095254 |
| 48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77854456 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75023839 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74470690 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73375900 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72438795 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69668609 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69516155 |
| 55 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69144394 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61105552 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59607942 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59110602 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.57067866 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55000375 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.53786665 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52464788 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.51361299 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49680435 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48860478 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47515797 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.45769891 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45610223 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45266902 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42281441 |
| 71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.41693865 |
| 72 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40238349 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40214433 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39143522 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38677269 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38642673 |
| 77 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38235718 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.35720295 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35034728 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34866960 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33680959 |
| 82 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33322233 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33028200 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31863133 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31839401 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31552989 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.31433097 |
| 88 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31211424 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30194507 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30160210 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28521348 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24882663 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24448822 |
| 94 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24435889 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21031993 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20482269 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19796174 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18295165 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17902193 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17881412 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16367861 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14203609 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13811478 |
| 104 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.13765398 |
| 105 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13551385 |
| 106 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13326028 |
| 107 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12260515 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11500113 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10818036 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 1.10796484 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10165327 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09619075 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09105828 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08927164 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08885858 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08858063 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.07914329 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07830072 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07236719 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06968955 |
| 121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05469692 |
| 122 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04819437 |
| 123 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04230479 |
| 124 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04165173 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03282430 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01919928 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01695805 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01695805 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01666747 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00395108 |
| 131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00297082 |
| 132 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99128001 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.98907191 |
| 134 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98722346 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98709143 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98699564 |
| 137 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98448706 |
| 138 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97607752 |
| 139 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97492880 |
| 140 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97342355 |
| 141 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97312987 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97077869 |
| 143 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96943353 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.96326958 |
| 145 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95620708 |
| 146 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95591296 |
| 147 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95289757 |
| 148 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95251691 |
| 149 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95203562 |
| 150 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94307361 |
| 151 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94150962 |
| 152 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93967070 |
| 153 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93884198 |
| 154 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92315514 |
| 155 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92079650 |
| 156 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91770467 |
| 157 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91533854 |
| 158 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91500648 |
| 159 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90811858 |
| 160 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90716841 |
| 161 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.90152833 |
| 162 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90050464 |
| 163 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90035967 |
| 164 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89988845 |
| 165 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89027192 |
| 166 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87962439 |
| 167 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87269296 |
| 168 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86838807 |
| 169 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86657823 |
| 170 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85606585 |
| 171 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85247356 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85056209 |
| 173 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84499390 |
| 174 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83501480 |
| 175 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83053511 |
| 176 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82240234 |
| 177 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.81962064 |
| 178 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81741850 |
| 179 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80897971 |
| 180 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.80789240 |
| 181 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79477071 |
| 182 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77998261 |
| 183 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.77701099 |
| 184 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.75861102 |
| 185 | STAT3_23295773_ChIP-Seq_U87_Human | 0.74841632 |
| 186 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.73035222 |
| 187 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.72827836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.77376541 |
| 2 | MP0003880_abnormal_central_pattern | 4.48456921 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.79925463 |
| 4 | MP0004270_analgesia | 3.35276190 |
| 5 | MP0003436_decreased_susceptibility_to | 3.34221817 |
| 6 | MP0003724_increased_susceptibility_to | 3.32170137 |
| 7 | MP0006082_CNS_inflammation | 3.20043962 |
| 8 | MP0002064_seizures | 3.19382156 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.10631865 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.09070470 |
| 11 | MP0009046_muscle_twitch | 3.05030471 |
| 12 | MP0009745_abnormal_behavioral_response | 3.01174254 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 3.00778816 |
| 14 | MP0003329_amyloid_beta_deposits | 2.78847645 |
| 15 | MP0009785_altered_susceptibility_to | 2.61795722 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.61682201 |
| 17 | MP0002419_abnormal_innate_immunity | 2.61203074 |
| 18 | MP0004858_abnormal_nervous_system | 2.56352247 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.53805082 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.52573535 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.51287091 |
| 22 | MP0002736_abnormal_nociception_after | 2.49557562 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.45679494 |
| 24 | MP0008260_abnormal_autophagy | 2.43355559 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.42484628 |
| 26 | MP0005025_abnormal_response_to | 2.34005756 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.26995119 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.26244553 |
| 29 | MP0001440_abnormal_grooming_behavior | 2.25505985 |
| 30 | MP0005000_abnormal_immune_tolerance | 2.22717636 |
| 31 | MP0005671_abnormal_response_to | 2.22627528 |
| 32 | MP0001790_abnormal_immune_system | 2.20937355 |
| 33 | MP0005387_immune_system_phenotype | 2.20937355 |
| 34 | MP0001970_abnormal_pain_threshold | 2.18943400 |
| 35 | MP0002272_abnormal_nervous_system | 2.12391092 |
| 36 | MP0006276_abnormal_autonomic_nervous | 2.11058302 |
| 37 | MP0003172_abnormal_lysosome_physiology | 2.01558568 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.99932291 |
| 39 | MP0000343_altered_response_to | 1.97151830 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.97125187 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.95958571 |
| 42 | MP0000604_amyloidosis | 1.91914509 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.87448101 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.87387306 |
| 45 | MP0002723_abnormal_immune_serum | 1.86887991 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.84328504 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.81921542 |
| 48 | MP0000685_abnormal_immune_system | 1.81502066 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.81440167 |
| 50 | MP0005451_abnormal_body_composition | 1.79198467 |
| 51 | MP0001486_abnormal_startle_reflex | 1.78877928 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.78687476 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.78232148 |
| 54 | MP0002822_catalepsy | 1.76126904 |
| 55 | MP0001800_abnormal_humoral_immune | 1.74985529 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.71427022 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.69610912 |
| 58 | MP0001819_abnormal_immune_cell | 1.68565975 |
| 59 | MP0002184_abnormal_innervation | 1.66982269 |
| 60 | MP0009764_decreased_sensitivity_to | 1.63138119 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.59672830 |
| 62 | MP0004924_abnormal_behavior | 1.49607810 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.49607810 |
| 64 | MP0003633_abnormal_nervous_system | 1.48185485 |
| 65 | MP0000778_abnormal_nervous_system | 1.46928678 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.46065851 |
| 67 | MP0008469_abnormal_protein_level | 1.45714669 |
| 68 | MP0003879_abnormal_hair_cell | 1.44936918 |
| 69 | MP0000955_abnormal_spinal_cord | 1.41978502 |
| 70 | MP0008569_lethality_at_weaning | 1.41458580 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.41170134 |
| 72 | MP0002557_abnormal_social/conspecific_i | 1.39666069 |
| 73 | MP0003303_peritoneal_inflammation | 1.39244189 |
| 74 | MP0004947_skin_inflammation | 1.39074767 |
| 75 | MP0000013_abnormal_adipose_tissue | 1.38521590 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 1.33234168 |
| 77 | MP0003075_altered_response_to | 1.32537310 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.27025916 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.26590726 |
| 80 | MP0002090_abnormal_vision | 1.26134720 |
| 81 | MP0004510_myositis | 1.25141961 |
| 82 | MP0001984_abnormal_olfaction | 1.24242997 |
| 83 | MP0002405_respiratory_system_inflammati | 1.23800092 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.23500124 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.22259671 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 1.21812796 |
| 87 | MP0003634_abnormal_glial_cell | 1.20094842 |
| 88 | MP0009278_abnormal_bone_marrow | 1.20064332 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.19215069 |
| 90 | MP0003122_maternal_imprinting | 1.18533045 |
| 91 | MP0000858_altered_metastatic_potential | 1.18488637 |
| 92 | MP0005535_abnormal_body_temperature | 1.17377243 |
| 93 | MP0003631_nervous_system_phenotype | 1.16402747 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 1.13932096 |
| 95 | MP0008961_abnormal_basal_metabolism | 1.13530025 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 1.12594023 |
| 97 | MP0008004_abnormal_stomach_pH | 1.12304691 |
| 98 | MP0001905_abnormal_dopamine_level | 1.10960332 |
| 99 | MP0004142_abnormal_muscle_tone | 1.10579460 |
| 100 | MP0001529_abnormal_vocalization | 1.10203763 |
| 101 | MP0000716_abnormal_immune_system | 1.10164340 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 1.08848402 |
| 103 | MP0003866_abnormal_defecation | 1.07941456 |
| 104 | MP0003283_abnormal_digestive_organ | 1.04874652 |
| 105 | MP0001853_heart_inflammation | 1.04108123 |
| 106 | MP0003183_abnormal_peptide_metabolism | 1.02024347 |
| 107 | MP0003690_abnormal_glial_cell | 1.01077044 |
| 108 | MP0000015_abnormal_ear_pigmentation | 1.00284302 |
| 109 | MP0003828_pulmonary_edema | 0.96512016 |
| 110 | MP0002229_neurodegeneration | 0.95711043 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.95654409 |
| 112 | MP0006054_spinal_hemorrhage | 0.95589241 |
| 113 | MP0005165_increased_susceptibility_to | 0.94679027 |
| 114 | MP0008874_decreased_physiological_sensi | 0.93808469 |
| 115 | MP0005365_abnormal_bile_salt | 0.92532509 |
| 116 | MP0003448_altered_tumor_morphology | 0.92248841 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90276569 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.90088103 |
| 119 | MP0001542_abnormal_bone_strength | 0.88927071 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.87863734 |
| 121 | MP0004885_abnormal_endolymph | 0.87844859 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.86859533 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.84602288 |
| 124 | MP0002152_abnormal_brain_morphology | 0.84003942 |
| 125 | MP0005166_decreased_susceptibility_to | 0.83123666 |
| 126 | MP0002398_abnormal_bone_marrow | 0.83078791 |
| 127 | MP0000920_abnormal_myelination | 0.82383455 |
| 128 | MP0002429_abnormal_blood_cell | 0.80800663 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.80613807 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.80613807 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.80368867 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.79016847 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.76940101 |
| 134 | MP0001851_eye_inflammation | 0.76917399 |
| 135 | MP0005390_skeleton_phenotype | 0.76376721 |
| 136 | MP0003632_abnormal_nervous_system | 0.76316252 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.75425619 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.74495260 |
| 139 | MP0002638_abnormal_pupillary_reflex | 0.72825351 |
| 140 | MP0002132_abnormal_respiratory_system | 0.72391097 |
| 141 | MP0009763_increased_sensitivity_to | 0.70762515 |
| 142 | MP0002722_abnormal_immune_system | 0.68839113 |
| 143 | MP0004043_abnormal_pH_regulation | 0.68326590 |
| 144 | MP0008872_abnormal_physiological_respon | 0.67662406 |
| 145 | MP0004130_abnormal_muscle_cell | 0.67459780 |
| 146 | MP0003795_abnormal_bone_structure | 0.67350346 |
| 147 | MP0004742_abnormal_vestibular_system | 0.66448507 |
| 148 | MP0005448_abnormal_energy_balance | 0.64222618 |
| 149 | MP0001663_abnormal_digestive_system | 0.63796565 |
| 150 | MP0000249_abnormal_blood_vessel | 0.63405242 |
| 151 | MP0001348_abnormal_lacrimal_gland | 0.62634002 |
| 152 | MP0004883_abnormal_blood_vessel | 0.60864324 |
| 153 | MP0005623_abnormal_meninges_morphology | 0.60411291 |
| 154 | MP0002118_abnormal_lipid_homeostasis | 0.60308609 |
| 155 | MP0009840_abnormal_foam_cell | 0.58084858 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.57294592 |
| 157 | MP0005310_abnormal_salivary_gland | 0.56941631 |
| 158 | MP0000538_abnormal_urinary_bladder | 0.56680242 |
| 159 | MP0005551_abnormal_eye_electrophysiolog | 0.55506500 |
| 160 | MP0002078_abnormal_glucose_homeostasis | 0.54267087 |
| 161 | MP0002693_abnormal_pancreas_physiology | 0.54265572 |
| 162 | MP0001177_atelectasis | 0.53728633 |
| 163 | MP0010329_abnormal_lipoprotein_level | 0.53488576 |
| 164 | MP0003195_calcinosis | 0.51503687 |
| 165 | MP0005164_abnormal_response_to | 0.49341279 |
| 166 | MP0001664_abnormal_digestion | 0.48723876 |
| 167 | MP0002877_abnormal_melanocyte_morpholog | 0.48283763 |
| 168 | MP0003638_abnormal_response/metabolism_ | 0.48055001 |
| 169 | MP0003953_abnormal_hormone_level | 0.48005907 |
| 170 | MP0000681_abnormal_thyroid_gland | 0.47670700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.09077728 |
| 2 | Myokymia (HP:0002411) | 5.28269323 |
| 3 | Visual hallucinations (HP:0002367) | 5.20718532 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.06051348 |
| 5 | Focal seizures (HP:0007359) | 4.89940964 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.71227683 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.53398646 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.44897424 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.39783468 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.27858695 |
| 11 | Loss of speech (HP:0002371) | 4.01305870 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.97517734 |
| 13 | Absence seizures (HP:0002121) | 3.91933263 |
| 14 | Atonic seizures (HP:0010819) | 3.90531775 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.79775778 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.69873623 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.69649041 |
| 18 | Dialeptic seizures (HP:0011146) | 3.66393695 |
| 19 | Disinhibition (HP:0000734) | 3.44939663 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.44128107 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.41977062 |
| 22 | Polyphagia (HP:0002591) | 3.31423413 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.31353011 |
| 24 | Mutism (HP:0002300) | 3.30234159 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.29238964 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.24857164 |
| 27 | Myositis (HP:0100614) | 3.23163863 |
| 28 | Febrile seizures (HP:0002373) | 3.15472620 |
| 29 | Amyloidosis (HP:0011034) | 3.11650615 |
| 30 | Action tremor (HP:0002345) | 3.09356502 |
| 31 | Stomatitis (HP:0010280) | 3.06974012 |
| 32 | Orchitis (HP:0100796) | 3.04961906 |
| 33 | Petechiae (HP:0000967) | 2.99190968 |
| 34 | Obstructive lung disease (HP:0006536) | 2.95201937 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95201937 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.93612868 |
| 37 | Progressive neurologic deterioration (HP:0002344) | 2.85319417 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.82198243 |
| 39 | Pheochromocytoma (HP:0002666) | 2.80793819 |
| 40 | Amblyopia (HP:0000646) | 2.80207543 |
| 41 | Depression (HP:0000716) | 2.77256281 |
| 42 | Failure to thrive in infancy (HP:0001531) | 2.76553327 |
| 43 | Purpura (HP:0000979) | 2.76487133 |
| 44 | Diplopia (HP:0000651) | 2.76437059 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.76437059 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.75155185 |
| 47 | Agitation (HP:0000713) | 2.71443778 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67784353 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.64297063 |
| 50 | Optic neuritis (HP:0100653) | 2.64297063 |
| 51 | Ankle clonus (HP:0011448) | 2.61856510 |
| 52 | Anxiety (HP:0000739) | 2.58878365 |
| 53 | Progressive inability to walk (HP:0002505) | 2.57980433 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57385756 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57385756 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57385756 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.54875656 |
| 58 | Recurrent skin infections (HP:0001581) | 2.54714001 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.50993052 |
| 60 | Abnormal social behavior (HP:0012433) | 2.50196358 |
| 61 | Impaired social interactions (HP:0000735) | 2.50196358 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47936583 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.47936583 |
| 64 | Apathy (HP:0000741) | 2.47757458 |
| 65 | Poor eye contact (HP:0000817) | 2.47685957 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.47586179 |
| 67 | Hypercortisolism (HP:0001578) | 2.47506588 |
| 68 | Truncal ataxia (HP:0002078) | 2.45335099 |
| 69 | Papilledema (HP:0001085) | 2.44633052 |
| 70 | Urticaria (HP:0001025) | 2.44046114 |
| 71 | Torticollis (HP:0000473) | 2.43873590 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43018591 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.42682894 |
| 74 | Status epilepticus (HP:0002133) | 2.42164413 |
| 75 | Hyperventilation (HP:0002883) | 2.42026159 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38772917 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38772917 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38772917 |
| 79 | Episodic fever (HP:0001954) | 2.38722281 |
| 80 | Diminished motivation (HP:0000745) | 2.37487702 |
| 81 | Global brain atrophy (HP:0002283) | 2.36928779 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.35398752 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35044013 |
| 84 | Increased serum ferritin (HP:0003281) | 2.34924288 |
| 85 | Postural instability (HP:0002172) | 2.34197246 |
| 86 | Limb dystonia (HP:0002451) | 2.31017456 |
| 87 | Hemiparesis (HP:0001269) | 2.30552979 |
| 88 | Focal dystonia (HP:0004373) | 2.29014927 |
| 89 | Dysdiadochokinesis (HP:0002075) | 2.28420462 |
| 90 | Gingivitis (HP:0000230) | 2.26612675 |
| 91 | Akinesia (HP:0002304) | 2.25377546 |
| 92 | Termporal pattern (HP:0011008) | 2.24902927 |
| 93 | Insidious onset (HP:0003587) | 2.24902927 |
| 94 | Dysmetria (HP:0001310) | 2.24161492 |
| 95 | Generalized myoclonic seizures (HP:0002123) | 2.23647066 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.23454282 |
| 97 | Psychosis (HP:0000709) | 2.21059545 |
| 98 | Recurrent fungal infections (HP:0002841) | 2.18647190 |
| 99 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.18081503 |
| 100 | Vertebral compression fractures (HP:0002953) | 2.17726558 |
| 101 | Genetic anticipation (HP:0003743) | 2.17578370 |
| 102 | Excessive salivation (HP:0003781) | 2.17270444 |
| 103 | Drooling (HP:0002307) | 2.17270444 |
| 104 | Amyotrophic lateral sclerosis (HP:0007354) | 2.16642627 |
| 105 | Craniofacial dystonia (HP:0012179) | 2.16053199 |
| 106 | Upper motor neuron abnormality (HP:0002127) | 2.14624611 |
| 107 | Rapidly progressive (HP:0003678) | 2.13913842 |
| 108 | Meningitis (HP:0001287) | 2.13677606 |
| 109 | Postural tremor (HP:0002174) | 2.13002857 |
| 110 | Hypoventilation (HP:0002791) | 2.12475769 |
| 111 | Interstitial pulmonary disease (HP:0006530) | 2.11979215 |
| 112 | Agnosia (HP:0010524) | 2.11896441 |
| 113 | Bradykinesia (HP:0002067) | 2.11819227 |
| 114 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.11765359 |
| 115 | Nuclear cataract (HP:0100018) | 2.10860454 |
| 116 | Malnutrition (HP:0004395) | 2.10276571 |
| 117 | Broad-based gait (HP:0002136) | 2.06300069 |
| 118 | Increased IgE level (HP:0003212) | 2.06168557 |
| 119 | Pulmonary infiltrates (HP:0002113) | 2.06106870 |
| 120 | Hypokinesia (HP:0002375) | 2.05585637 |
| 121 | Spontaneous hematomas (HP:0007420) | 2.04862834 |
| 122 | Gingival bleeding (HP:0000225) | 2.03109960 |
| 123 | Clumsiness (HP:0002312) | 2.03019638 |
| 124 | Dementia (HP:0000726) | 2.02934532 |
| 125 | Intention tremor (HP:0002080) | 2.02698926 |
| 126 | Rigidity (HP:0002063) | 1.99926037 |
| 127 | Personality changes (HP:0000751) | 1.98206222 |
| 128 | Abnormality of the lower motor neuron (HP:0002366) | 1.97031984 |
| 129 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94893885 |
| 130 | Autoimmune thrombocytopenia (HP:0001973) | 1.94201973 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.92808047 |
| 132 | Urinary urgency (HP:0000012) | 1.92607381 |
| 133 | Axonal loss (HP:0003447) | 1.91885060 |
| 134 | Oligomenorrhea (HP:0000876) | 1.90647097 |
| 135 | Stereotypic behavior (HP:0000733) | 1.89691899 |
| 136 | Cellulitis (HP:0100658) | 1.89283290 |
| 137 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88936188 |
| 138 | Increased IgM level (HP:0003496) | 1.88649489 |
| 139 | Vasculitis (HP:0002633) | 1.88040016 |
| 140 | Delusions (HP:0000746) | 1.87903442 |
| 141 | Pathologic fracture (HP:0002756) | 1.87812294 |
| 142 | Spastic gait (HP:0002064) | 1.87215934 |
| 143 | Restlessness (HP:0000711) | 1.86805112 |
| 144 | Glomerulonephritis (HP:0000099) | 1.86510719 |
| 145 | Hemoptysis (HP:0002105) | 1.83853040 |
| 146 | Gastrointestinal infarctions (HP:0005244) | 1.82666627 |
| 147 | Myocardial infarction (HP:0001658) | 1.81788216 |
| 148 | Hand muscle atrophy (HP:0009130) | 1.81466134 |
| 149 | Hypergammaglobulinemia (HP:0010702) | 1.80772691 |
| 150 | Retinal atrophy (HP:0001105) | 1.80650491 |
| 151 | Impaired smooth pursuit (HP:0007772) | 1.78663154 |
| 152 | Abnormality of the corticospinal tract (HP:0002492) | 1.78275171 |
| 153 | Absent speech (HP:0001344) | 1.78067449 |
| 154 | Inappropriate behavior (HP:0000719) | 1.78018807 |
| 155 | Memory impairment (HP:0002354) | 1.75874826 |
| 156 | Epistaxis (HP:0000421) | 1.73683411 |
| 157 | Basal ganglia calcification (HP:0002135) | 1.73121914 |
| 158 | Polyneuropathy (HP:0001271) | 1.72969496 |
| 159 | Increased CSF protein (HP:0002922) | 1.72772382 |
| 160 | Chest pain (HP:0100749) | 1.72364213 |
| 161 | Cardiomegaly (HP:0001640) | 1.71699397 |
| 162 | Abnormality of the nasal mucosa (HP:0000433) | 1.71129192 |
| 163 | Keratoconjunctivitis sicca (HP:0001097) | 1.70306250 |
| 164 | Abnormal gallbladder physiology (HP:0012438) | 1.68335227 |
| 165 | Cholecystitis (HP:0001082) | 1.68335227 |
| 166 | Asymmetric septal hypertrophy (HP:0001670) | 1.67644979 |
| 167 | Encephalitis (HP:0002383) | 1.65596269 |
| 168 | Abnormality of the motor neurons (HP:0002450) | 1.64669322 |
| 169 | Abnormal neuron morphology (HP:0012757) | 1.64669322 |
| 170 | Pustule (HP:0200039) | 1.64079868 |
| 171 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.62003777 |
| 172 | Recurrent cutaneous fungal infections (HP:0011370) | 1.62003777 |
| 173 | Osteomyelitis (HP:0002754) | 1.57767311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.37790048 |
| 2 | NTRK3 | 3.68676237 |
| 3 | RIPK4 | 3.34787237 |
| 4 | EPHA4 | 3.07724208 |
| 5 | MAP3K12 | 3.05895557 |
| 6 | MARK1 | 2.94897905 |
| 7 | TESK2 | 2.87375704 |
| 8 | KSR2 | 2.86367706 |
| 9 | MAP3K4 | 2.64710388 |
| 10 | MINK1 | 2.59254707 |
| 11 | BLK | 2.54516846 |
| 12 | DAPK2 | 2.51808152 |
| 13 | NTRK1 | 2.32816726 |
| 14 | MAP3K3 | 2.24599870 |
| 15 | ARAF | 2.23034930 |
| 16 | TYK2 | 2.13719869 |
| 17 | PAK6 | 2.12285358 |
| 18 | MAP2K3 | 2.08076626 |
| 19 | MAP2K4 | 2.06597699 |
| 20 | MAP2K7 | 2.03449231 |
| 21 | IRAK3 | 2.02572191 |
| 22 | IRAK4 | 2.00150990 |
| 23 | TBK1 | 1.92477824 |
| 24 | CSK | 1.76416874 |
| 25 | MAP3K2 | 1.74588234 |
| 26 | MAP4K1 | 1.73314686 |
| 27 | CAMKK1 | 1.71658930 |
| 28 | TAOK2 | 1.71601500 |
| 29 | NTRK2 | 1.69589267 |
| 30 | EPHB1 | 1.68388732 |
| 31 | KSR1 | 1.68056343 |
| 32 | GRK5 | 1.66447391 |
| 33 | DAPK1 | 1.63015556 |
| 34 | ZAP70 | 1.54736058 |
| 35 | PLK2 | 1.50840639 |
| 36 | GRK6 | 1.40739156 |
| 37 | CDK19 | 1.39518142 |
| 38 | CDK5 | 1.39256964 |
| 39 | PRKD3 | 1.39153274 |
| 40 | TNK2 | 1.39084941 |
| 41 | TGFBR2 | 1.28964040 |
| 42 | SCYL2 | 1.26937426 |
| 43 | PNCK | 1.26563916 |
| 44 | CAMKK2 | 1.25762528 |
| 45 | GRK7 | 1.17174945 |
| 46 | PIM2 | 1.16377098 |
| 47 | RET | 1.13373345 |
| 48 | LATS2 | 1.13222666 |
| 49 | MAP3K1 | 1.10393882 |
| 50 | PRKD2 | 1.09834333 |
| 51 | FES | 1.08965902 |
| 52 | IKBKE | 1.08067476 |
| 53 | CASK | 1.07057002 |
| 54 | TRIB3 | 1.06623829 |
| 55 | PRKCG | 1.05528594 |
| 56 | MAP3K13 | 1.05232265 |
| 57 | SIK2 | 1.04408997 |
| 58 | NME2 | 1.03802402 |
| 59 | MAP3K14 | 1.03278888 |
| 60 | PDK2 | 1.02235538 |
| 61 | IKBKB | 0.98694933 |
| 62 | UHMK1 | 0.96587257 |
| 63 | HCK | 0.94927045 |
| 64 | LYN | 0.93234286 |
| 65 | CDK14 | 0.92764064 |
| 66 | TYRO3 | 0.91967343 |
| 67 | JAK2 | 0.90728609 |
| 68 | MAP3K11 | 0.88112959 |
| 69 | FGR | 0.87729707 |
| 70 | JAK3 | 0.87681119 |
| 71 | PAK4 | 0.86097548 |
| 72 | CDK18 | 0.85008219 |
| 73 | TAOK1 | 0.83947878 |
| 74 | CSF1R | 0.82634431 |
| 75 | CAMK2A | 0.82239285 |
| 76 | CDK15 | 0.81466345 |
| 77 | PRKG2 | 0.80444638 |
| 78 | PAK3 | 0.80096378 |
| 79 | IRAK2 | 0.79879129 |
| 80 | MAP2K6 | 0.78413688 |
| 81 | MAPK12 | 0.77134151 |
| 82 | BCKDK | 0.76722863 |
| 83 | BMPR2 | 0.75781626 |
| 84 | DAPK3 | 0.75093372 |
| 85 | MAP2K1 | 0.74530006 |
| 86 | ERN1 | 0.74219791 |
| 87 | PDPK1 | 0.74066630 |
| 88 | STK38 | 0.73255859 |
| 89 | RAF1 | 0.72234933 |
| 90 | CDK11A | 0.71945676 |
| 91 | PTK2B | 0.71753197 |
| 92 | CSNK1G2 | 0.71655923 |
| 93 | FER | 0.70163910 |
| 94 | JAK1 | 0.69840449 |
| 95 | PRKCH | 0.68020438 |
| 96 | CSNK1G3 | 0.67006266 |
| 97 | MARK2 | 0.66902912 |
| 98 | LCK | 0.66376988 |
| 99 | PRKCZ | 0.65926073 |
| 100 | CDC42BPA | 0.65386507 |
| 101 | SIK3 | 0.64504035 |
| 102 | BTK | 0.64387701 |
| 103 | EPHA3 | 0.64248350 |
| 104 | RIPK1 | 0.63844892 |
| 105 | ABL2 | 0.63655528 |
| 106 | MAPKAPK3 | 0.63471226 |
| 107 | BMX | 0.62426937 |
| 108 | SGK494 | 0.61669919 |
| 109 | SGK223 | 0.61669919 |
| 110 | MARK3 | 0.61273073 |
| 111 | DDR2 | 0.60886322 |
| 112 | PHKG2 | 0.59765991 |
| 113 | PHKG1 | 0.59765991 |
| 114 | TXK | 0.59731494 |
| 115 | PRKCE | 0.59471161 |
| 116 | BRAF | 0.59395521 |
| 117 | CAMK2B | 0.59351140 |
| 118 | WNK3 | 0.59151151 |
| 119 | PDK1 | 0.58474395 |
| 120 | MAPK13 | 0.56507635 |
| 121 | LIMK1 | 0.56427430 |
| 122 | ALK | 0.53904154 |
| 123 | KDR | 0.49336630 |
| 124 | FYN | 0.48855272 |
| 125 | PTK2 | 0.48317702 |
| 126 | MAP3K6 | 0.47941707 |
| 127 | RPS6KA2 | 0.47749582 |
| 128 | STK11 | 0.46197087 |
| 129 | SGK3 | 0.44836041 |
| 130 | PRKD1 | 0.44177527 |
| 131 | PRKCD | 0.43286034 |
| 132 | CSNK1A1L | 0.43284743 |
| 133 | OXSR1 | 0.41529321 |
| 134 | PTK6 | 0.41421951 |
| 135 | PRPF4B | 0.40794070 |
| 136 | MST1R | 0.40645240 |
| 137 | MAP3K5 | 0.40363835 |
| 138 | IRAK1 | 0.40229068 |
| 139 | SIK1 | 0.39856057 |
| 140 | DYRK1A | 0.39742419 |
| 141 | NME1 | 0.39206290 |
| 142 | MOS | 0.39206029 |
| 143 | CAMK2G | 0.38990441 |
| 144 | SGK1 | 0.38676942 |
| 145 | SYK | 0.38582392 |
| 146 | CAMK1 | 0.37544302 |
| 147 | MAPKAPK2 | 0.37044803 |
| 148 | CAMK1G | 0.34951105 |
| 149 | MATK | 0.33637853 |
| 150 | CAMK2D | 0.33326711 |
| 151 | PINK1 | 0.33151998 |
| 152 | TESK1 | 0.31775239 |
| 153 | LMTK2 | 0.31545072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.99573249 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.46039554 |
| 3 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.82587294 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.78460063 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53742486 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.48273587 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41092200 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.30235562 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.17205143 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12847342 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10616610 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.07675621 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02637183 |
| 14 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.01204331 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94085134 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.91103718 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.89814111 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.87538353 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.87272140 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.85996879 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83656691 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76427569 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.76205333 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.71437937 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.67855385 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.64431211 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56216938 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.53833324 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.50140933 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50127242 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.48140857 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.47062906 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43189591 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41612237 |
| 35 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40272198 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39564506 |
| 37 | * Lysosome_Homo sapiens_hsa04142 | 1.34081308 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.33413531 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33021537 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.32339053 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.31863658 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30836063 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25793041 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25321751 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23262334 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19738608 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.19524211 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19324149 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18749349 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17693993 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17260014 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17258169 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 1.16783358 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15738047 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15234842 |
| 56 | * Phagosome_Homo sapiens_hsa04145 | 1.13685139 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13044795 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12649839 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12161229 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11535438 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10267786 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09231236 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09196274 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08638217 |
| 65 | Glioma_Homo sapiens_hsa05214 | 1.06340960 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05864273 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05790076 |
| 68 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04624578 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03212327 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99344576 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97481986 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95086482 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.94995434 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94817329 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91162774 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90205523 |
| 77 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89625603 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.88238366 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85952662 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85437621 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84223579 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.81880502 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81017234 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80759777 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79454956 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78471793 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77828164 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77638427 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75652656 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73895519 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.73681568 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72327958 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.71667827 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70451128 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68403793 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66857442 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66812562 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66804974 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66104373 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.65243278 |
| 101 | * Tuberculosis_Homo sapiens_hsa05152 | 0.65242738 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.62870882 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62138896 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61390404 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60201256 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58744777 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58455544 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57021930 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56790554 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56191881 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56035678 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55883672 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55137629 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54693834 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.54693360 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54437417 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53704566 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52655055 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52330782 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51853783 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51511322 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.51368507 |
| 123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51197551 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50545915 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49424367 |
| 126 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48121681 |
| 127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46231183 |
| 128 | Phototransduction_Homo sapiens_hsa04744 | 0.45308395 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45184595 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.44466112 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44279437 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43138047 |
| 133 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43043222 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42983768 |
| 135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42626467 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.42493185 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41595953 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41221174 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39001160 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38430272 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38271933 |
| 142 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37992755 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.37772950 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37650319 |
| 145 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37046261 |
| 146 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34402546 |
| 147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33961535 |
| 148 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33638858 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33395732 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33171475 |
| 151 | Amoebiasis_Homo sapiens_hsa05146 | 0.31988604 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | 0.31230116 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31004134 |
| 154 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30288475 |
| 155 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29921541 |
| 156 | Bladder cancer_Homo sapiens_hsa05219 | 0.24462776 |
| 157 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22885551 |
| 158 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22489977 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22086533 |

